InvestorsHub Logo
Followers 22
Posts 1789
Boards Moderated 0
Alias Born 09/03/2004

Re: m0n post# 80799

Monday, 11/03/2014 5:44:54 PM

Monday, November 03, 2014 5:44:54 PM

Post# of 91007
http://online.barrons.com/articles/new-fda-guidance-target-cellular-therapy-1415048504


IntelliCell BioSciences ( SVFC ) has developed an autologous product called stromal vascular fraction cells. This technology uses ultrasound, rather than enzymes or agents, to separate vascular cells from a sample of adipose tissue. It then transplants them back to the donor. This process seems to fit the definitions of “autologous” and “minimally manipulated.”

L6

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.